Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Up to eleven

Factor XI-inhibiting anticoagulants could also ease arterial hypertension

Factor XI inhibitors may not only have safety advantages over more established anticoagulants, but could come with blood pressure-lowering benefits as well. A Science Translational Medicine study from Ionis Pharmaceuticals Inc. (NASDAQ:IONS) and Johannes Gutenberg University Mainz has shown Factor XI-targeting antisense oligos (ASOs) decrease arterial hypertension by shutting down a feedback loop that fuels inflammation at blood vessel walls, creating new value

Read the full 632 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE